-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Upgrades Spruce Biosciences to Market Outperform, Announces $254 Price Target

Benzinga·10/28/2025 13:24:10
Listen to the news
JMP Securities analyst Jonathan Wolleben upgrades Spruce Biosciences (NASDAQ:SPRB) from Market Perform to Market Outperform and announces $254 price target.